BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36232600)

  • 61. Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells.
    Tanimoto A; Murata Y; Wang KY; Tsutsui M; Kohno K; Sasaguri Y
    J Biol Chem; 2008 Feb; 283(8):4643-51. PubMed ID: 18089573
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development.
    Nakasato M; Shirakura Y; Ooga M; Iwatsuki M; Ito M; Kageyama S; Sakai S; Nagata M; Aoki F
    Biol Reprod; 2006 Oct; 75(4):508-17. PubMed ID: 16775227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
    Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
    J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2.
    Ren Z; Aerts JL; Vandenplas H; Wang JA; Gorbenko O; Chen JP; Giron P; Heirman C; Goyvaerts C; Zacksenhaus E; Minden MD; Stambolic V; Breckpot K; De Grève J
    Cell Death Dis; 2016 Dec; 7(12):e2560. PubMed ID: 28005077
    [TBL] [Abstract][Full Text] [Related]  

  • 65. M-CSF and GM-CSF regulation of STAT5 activation and DNA binding in myeloid cell differentiation is disrupted in nonobese diabetic mice.
    Rumore-Maton B; Elf J; Belkin N; Stutevoss B; Seydel F; Garrigan E; Litherland SA
    Clin Dev Immunol; 2008; 2008():769795. PubMed ID: 19165346
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [STAT5B deficiency: a new growth hormone insensitivity syndrome associated to immunological dysfunction].
    Scalco RC; Pugliese-Pires PN; Jorge AA
    Arq Bras Endocrinol Metabol; 2013 Jul; 57(5):333-8. PubMed ID: 23896798
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.
    Bibi S; Arslanhan MD; Langenfeld F; Jeanningros S; Cerny-Reiterer S; Hadzijusufovic E; Tchertanov L; Moriggl R; Valent P; Arock M
    Haematologica; 2014 Mar; 99(3):417-29. PubMed ID: 24598853
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia.
    Theodorou M; Speletas M; Mamara A; Papachristopoulou G; Lazou V; Scorilas A; Katsantoni E
    PLoS One; 2013; 8(10):e76155. PubMed ID: 24155890
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neither signal transducer and activator of transcription 3 (STAT3) or STAT5 signaling pathways are required for leptin's effects on fertility in mice.
    Singireddy AV; Inglis MA; Zuure WA; Kim JS; Anderson GM
    Endocrinology; 2013 Jul; 154(7):2434-45. PubMed ID: 23696567
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer.
    Xiong H; Du W; Wang JL; Wang YC; Tang JT; Hong J; Fang JY
    J Mol Med (Berl); 2012 Sep; 90(9):1037-46. PubMed ID: 22328012
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting.
    Koppikar P; Lui VW; Man D; Xi S; Chai RL; Nelson E; Tobey AB; Grandis JR
    Clin Cancer Res; 2008 Dec; 14(23):7682-90. PubMed ID: 19047094
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
    Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
    Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
    Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
    Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses.
    Bourgeais J; Ishac N; Medrzycki M; Brachet-Botineau M; Desbourdes L; Gouilleux-Gruart V; Pecnard E; Rouleux-Bonnin F; Gyan E; Domenech J; Mazurier F; Moriggl R; Bunting KD; Herault O; Gouilleux F
    Oncotarget; 2017 Jun; 8(26):41876-41889. PubMed ID: 27566554
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protein complexes and target genes identification by in vivo biotinylation: the STAT5 paradigm.
    Katsantoni E
    Sci Signal; 2012 Oct; 5(248):pt13. PubMed ID: 23112345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
    Nevalainen MT; Xie J; Torhorst J; Bubendorf L; Haas P; Kononen J; Sauter G; Rui H
    J Clin Oncol; 2004 Jun; 22(11):2053-60. PubMed ID: 15169792
    [TBL] [Abstract][Full Text] [Related]  

  • 77. How Intrinsic Molecular Dynamics Control Intramolecular Communication in Signal Transducers and Activators of Transcription Factor STAT5.
    Langenfeld F; Guarracino Y; Arock M; Trouvé A; Tchertanov L
    PLoS One; 2015; 10(12):e0145142. PubMed ID: 26717567
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design and use of constitutively active STAT5 constructs.
    Farrar MA
    Methods Enzymol; 2010; 485():583-96. PubMed ID: 21050937
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.
    Fatrai S; Wierenga AT; Daenen SM; Vellenga E; Schuringa JJ
    Blood; 2011 Mar; 117(12):3320-30. PubMed ID: 21263150
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.
    Qian L; Lopez V; Seo YA; Kelleher SL
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C369-77. PubMed ID: 19494234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.